BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18294935)

  • 1. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
    Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
    Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis.
    Schrickel JW; Schwab JO; Yang A; Bitzen A; Lüderitz B; Lewalter T
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):363-6. PubMed ID: 16650263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes induced by short-term oral amiodarone therapy.
    Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
    Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proarrhythmia caused by amiodarone].
    Pagano L; Della Monica R; Malinconico M
    Minerva Cardioangiol; 2001 Dec; 49(6):421-8. PubMed ID: 11733739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety considerations in the pharmacological management of atrial fibrillation.
    Camm AJ
    Int J Cardiol; 2008 Jul; 127(3):299-306. PubMed ID: 18191470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female preponderance in ibutilide-induced torsade de pointes.
    Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
    Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm.
    Sideris S; Bonios M; Melexopoulou C; Exarchos P; Tsatiris K; Kogias J
    Cardiology; 2007; 107(4):399-401. PubMed ID: 17284902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amiodarone-induced torsade de pointes--five case reports].
    Kukla P; Słowiak-Lewińska T
    Kardiol Pol; 2004 Apr; 60(4):365-70; discussion 371. PubMed ID: 15226788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.
    Takahashi K; Yamashita M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S; Takemoto M; Utsunomiya Y; Hyodo T
    Ann Noninvasive Electrocardiol; 2021 Nov; 26(6):e12842. PubMed ID: 33755267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.